tetano
Editor, Senior Moderator
Vaccine
. 2024 Sep 17;42(26):126322.
doi: 10.1016/j.vaccine.2024.126322. Online ahead of print. An evaluation of the National Influenza Vaccination Program in the Republic of Moldova, 2023-2024
Angela K Shen[SUP] 1 [/SUP], Veaceslav Gutu[SUP] 2 [/SUP], Alina Druc[SUP] 2 [/SUP], Malembe Ebama[SUP] 3 [/SUP], Asalif Belayneh[SUP] 3 [/SUP], Brittany Adams[SUP] 4 [/SUP], Molly Valleau[SUP] 4 [/SUP], Angela Paraschiv[SUP] 5 [/SUP]
Affiliations
During the 2023-2024 influenza season, the Republic of Moldova, a lower-middle income country seeking accession into the European Union, independently financed their influenza vaccine supply transitioning from external support from the Partnership for International Vaccine Initiatives, a collaboration conceived in 2015. As part of this transition, a mixed-methods evaluation was conducted from May 2023 - January 2024 to identify current strengths and weaknesses of the influenza vaccination program. A total of 157 interviews were conducted: one with the National Immunization Program (NIP), six with district health officers, 18 at health facilities, 18 with caregivers/parents, 34 with healthcare workers, 43 with adults with chronic diseases, 19 with pregnant women, and 13 vaccine observation sessions; further five expert interviews with an international organization, the insurance company, senior government officials in public health and within the ministry of health, and those involved with COVID-19 were conducted. The Republic of Moldova's NIP has benefited from decades of experience, internal commitments to progress, and contributions from external partners. Despite this progress, the evaluation recognized four areas for improvement. Recommendations from the evaluation assessment included: 1) develop a national strategy for immunization, including the establishment of national goals in consultation with the national immunization technical advisory group (NITAG); 2) expand immunization communications and advocacy initiatives, particularly to adults and pregnant individuals; 3) leverage trusted patient-doctor relationships and encourage vaccination as a healthcare norm with physician specialists; and 4) conduct operations research to better understand vaccine hesitancy in populations such as pregnant individuals. Additional thematic findings emphasized the importance of ensuring timely receipt of vaccine doses into the country no later than September, as medical providers reported difficulty administering doses when vaccines were delivered after September. Our findings outline ways to further strengthen the Republic of Moldova's self-sustained annual influenza vaccination program.
Keywords: Influenza; Pandemic readiness; Sustainable financing.
. 2024 Sep 17;42(26):126322.
doi: 10.1016/j.vaccine.2024.126322. Online ahead of print. An evaluation of the National Influenza Vaccination Program in the Republic of Moldova, 2023-2024
Angela K Shen[SUP] 1 [/SUP], Veaceslav Gutu[SUP] 2 [/SUP], Alina Druc[SUP] 2 [/SUP], Malembe Ebama[SUP] 3 [/SUP], Asalif Belayneh[SUP] 3 [/SUP], Brittany Adams[SUP] 4 [/SUP], Molly Valleau[SUP] 4 [/SUP], Angela Paraschiv[SUP] 5 [/SUP]
Affiliations
- PMID: 39293299
- DOI: 10.1016/j.vaccine.2024.126322
During the 2023-2024 influenza season, the Republic of Moldova, a lower-middle income country seeking accession into the European Union, independently financed their influenza vaccine supply transitioning from external support from the Partnership for International Vaccine Initiatives, a collaboration conceived in 2015. As part of this transition, a mixed-methods evaluation was conducted from May 2023 - January 2024 to identify current strengths and weaknesses of the influenza vaccination program. A total of 157 interviews were conducted: one with the National Immunization Program (NIP), six with district health officers, 18 at health facilities, 18 with caregivers/parents, 34 with healthcare workers, 43 with adults with chronic diseases, 19 with pregnant women, and 13 vaccine observation sessions; further five expert interviews with an international organization, the insurance company, senior government officials in public health and within the ministry of health, and those involved with COVID-19 were conducted. The Republic of Moldova's NIP has benefited from decades of experience, internal commitments to progress, and contributions from external partners. Despite this progress, the evaluation recognized four areas for improvement. Recommendations from the evaluation assessment included: 1) develop a national strategy for immunization, including the establishment of national goals in consultation with the national immunization technical advisory group (NITAG); 2) expand immunization communications and advocacy initiatives, particularly to adults and pregnant individuals; 3) leverage trusted patient-doctor relationships and encourage vaccination as a healthcare norm with physician specialists; and 4) conduct operations research to better understand vaccine hesitancy in populations such as pregnant individuals. Additional thematic findings emphasized the importance of ensuring timely receipt of vaccine doses into the country no later than September, as medical providers reported difficulty administering doses when vaccines were delivered after September. Our findings outline ways to further strengthen the Republic of Moldova's self-sustained annual influenza vaccination program.
Keywords: Influenza; Pandemic readiness; Sustainable financing.